Atorvastatin attenuates oxidative stress in patients with chronic kidney disease
Marcin Renke, Narcyz Knap, Leszek Tylicki, Przemyslaw Rutkowski, Alexander Neuwelt, Wojciech Larczynski, Michal Wozniak, Boleslaw Rutkowski
Med Sci Monit 2010; 16(3): LET3-3
ID: 878467
Published: 2010-02-26
Keywords: Pyrroles - therapeutic use, Oxidative Stress - drug effects, Placebos, Kidney Failure, Chronic - urine, Male, Isoprostanes - urine, Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use, Humans, Heptanoic Acids - therapeutic use, Female, Adult
